[go: up one dir, main page]

mit breitem Wirkungsspektrum - Google Patents

Development of enhanced furin inhibitors with reduced toxicity as potential broad spectrum antiviral drugs Entwicklung optimierter Furinhemmstoffe mit reduzierter …

mit breitem Wirkungsspektrum

View PDF
Document ID
9799694803295645017
Author
mit breitem Wirkungsspektrum W

External Links

Snippet

At the beginning of the twentieth century, the focus of peptide research was largely on human signalling hormones. A breakthrough in the field of peptide therapeutics was the first medicinal application of insulin isolated from animal pancreas, which revolutionized the …
Continue reading at archiv.ub.uni-marburg.de (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Similar Documents

Publication Publication Date Title
Senapati et al. Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
Pišlar et al. The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors
Becker et al. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics
Osman et al. Why all the fury over furin?
Llinas-Brunet et al. Peptide-based inhibitors of the hepatitis C virus serine protease
Garten Characterization of proprotein convertases and their involvement in virus propagation
Kouretova et al. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
Van Lam van et al. Design, synthesis, and characterization of macrocyclic inhibitors of the proprotein convertase furin
Hundt et al. Post-translational modifications of hepatitis C viral proteins and their biological significance
Huber et al. Structure-based optimization and characterization of macrocyclic zika virus NS2B-NS3 protease inhibitors
Gagnon et al. Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin
Tripathi et al. COVID-19: inflammatory responses, structure-based drug design and potential therapeutics
RU2451026C2 (en) Chimeric peptide molecules with antiviral properties with respect to viruses family flaviviridae
US8865865B2 (en) N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic
Remacle et al. Selective and potent furin inhibitors protect cells from anthrax without significant toxicity
Wędrowska et al. Coronaviruses fusion with the membrane and entry to the host cell
Müller et al. Interfering with host proteases in SARS-CoV-2 entry as a promising therapeutic strategy
Russell et al. Influenza glycoproteins: Hemagglutinin and neuraminidase
Ivachtchenko et al. Development and Prospects of Furin Inhibitors for Therapeutic Applications
Colombo et al. Optimization of Ketobenzothiazole‐Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication
AU2005292135B2 (en) Inhibitors of hepatitits C virus
mit breitem Wirkungsspektrum Development of enhanced furin inhibitors with reduced toxicity as potential broad spectrum antiviral drugs Entwicklung optimierter Furinhemmstoffe mit reduzierter Toxizität als potenzielle antivirale
US10538554B2 (en) Peptides and uses therefor as antiviral agents
Quagliata et al. Chemically modified antiviral peptides against SARS‐CoV‐2
US11376306B2 (en) Peptides and uses therefor as antiviral agents